SOCRA CCRP Practice Exam 2025 - Free CCRP Practice Questions and Study Guide

After submitting an IND, a sponsor must wait at least 30 calendar days before beginning any clinical investigations. This allows the FDA to review the IND and make a decision on whether it is safe to begin testing the drug or device on humans. Option A (15 calendar days) is incorrect because it does not provide enough time for the FDA to review the IND. Option C (45 calendar days) and Option D (60 calendar days) are both incorrect because they are longer than the required waiting period. Therefore, Option B (30 calendar days) is the correct and most suitable choice.